Browsing Tag

Biomedical

Antiangiogenics in Malignant Pleural Mesothelioma: Recent Research Context

Malignant pleural mesothelioma (MPM) is a tough treatment course to navigate. If anyone knows that, it is Anne S. Tsao, MD. of MD Anderson Cancer Center in Houston. Tsao is no doubt one of the world's experts on MPM, having been "called" by the disease – one that is very rare and that generally occurs in older men (most often because of asbestos exposure) with comorbidities. Tsao told the West Wind Podcast that she was intrigued by MPM early in her career because "it was so different than . I just started doing some

Understanding the Biomedical Model

Traditionally, western medicine has been centred around the biomedical model and its underpinning philosophies to best determine a person’s health status. The biomedical model has allowed medicine to advance in leaps and bounds over recent decades, improving our understanding of the human body while also maintaining a superior standard of care through the evidence-based practice approach. Through this approach, we were able to isolate body systems and understand disease processes and how they impacted upon the individual…

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More